LAIR1 and neoplasm: SP-D acts as a ligand for the inhibitory receptor LAIR-1, which inhibits the function of multiple types of immune cells (45), indicating that SP-D present in the tumor microenvironment may exert its immunomodulatory effect and inhibit the anti-tumor immune responses through LAIR-1 activation.